KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 113 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $134,387 | +391.3% | 13,955 | +359.2% | 0.00% | – |
Q2 2023 | $27,351 | +351.0% | 3,039 | +238.8% | 0.00% | – |
Q4 2022 | $6,064 | -87.1% | 897 | -66.6% | 0.00% | – |
Q3 2021 | $47,000 | +4.4% | 2,689 | +42.0% | 0.00% | – |
Q2 2021 | $45,000 | -44.4% | 1,894 | -40.2% | 0.00% | – |
Q1 2021 | $81,000 | +1925.0% | 3,169 | +1423.6% | 0.00% | – |
Q4 2020 | $4,000 | – | 208 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 422,310 | $10,849,000 | 5.86% |
COMMODORE CAPITAL LP | 214,467 | $5,510,000 | 2.20% |
Vivo Capital, LLC | 1,863,296 | $47,868,000 | 1.68% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 214,533 | $5,486,000 | 1.45% |
Nicholas Investment Partners, LP | 594,130 | $15,263,000 | 1.06% |
Altium Capital Management LP | 128,130 | $3,292,000 | 0.91% |
Affinity Asset Advisors, LLC | 100,000 | $2,569,000 | 0.87% |
SILVERARC CAPITAL MANAGEMENT, LLC | 50,000 | $1,285,000 | 0.70% |
APIS CAPITAL ADVISORS, LLC | 30,000 | $771,000 | 0.70% |
Birchview Capital, LP | 40,000 | $1,028,000 | 0.61% |